Skip to main content

Macrophages as Biomarkers of Non-Alcoholic Fatty Liver Disease Progression

 Non-alcoholic fatty liver disease (NAFLD), as its name indicated, is a condition caused by abnormal or excessive fat buildup in liver, which is not a result of heavy alcohol use. It has become a common chronic liver disease and is affecting up to 25% of people worldwide. Most people have no symptoms, and 2% to 5% of people will experience complications from the fat in their liver and a more serious condition named non-alcoholic steatohepatitis (NASH) due to liver inflammation and cell damage, which ultimately could develop into liver cirrhosis. Thus, early detection is important before some irreversible results in the liver disease progression pose clinical and economic burdens.

 

Evidence shows that changes in immune cells in the liver are related to the development of NAFLD. And the presence of chronic low-grade inflammation characterized by immune cell activation, abnormal cytokine production, and increased acute phase proteins is a hallmark of NAFLD. Particularly, macrophages, as part of the immune system, are considered key mediators responsible for the initiation and propagation of hepatic inflammation and the regulation of fibrosis. However, it's investigated that macrophages in the liver show substantial heterogeneity, meaning they could influence disease progression in different ways by interaction with other hepatic cells.

 

Recent research published on the Journal of Hepatology has identified that a specific subtype of macrophages derived from bone marrow plays an important role in progressive NAFLD. The study demonstrated the association between murine steatohepatitis and a hepatic transcriptomic profile characterized by hyperlipidemia-dependent induction of Triggering receptor expressed on myeloid cells 2 (TREM2 ). Researchers displayed the protective function of these specific immune cells in fibrosis and liver cirrhosis through the animal model. To be specific, an increased accumulation of macrophages that highly express the receptor TREM2 is identified in the affected areas of the NASH inflammation, particularly in areas of cellular damage, oxidative stress, and fibrosis. Moreover, bone marrow transplantation models further demonstrate that hematopoietic TREM2 deficiency negatively impacts fat storage and the breakdown of excess connective tissue, which further increases steatohepatitis, cell death, and fibrosis.

 

Given the functional properties of TREM2-positive (TREM2+) macrophages in NAFLD, especially in preventing fat accumulation, inflammatory processes, and progression of NAFLD to liver fibrosis, these cells are promising for developing new NASH therapy targeting infiltrating immune cells.

 

Besides, TREM2 exists in membrane binding receptor form on cells and in soluble form (sTREM2) that can be measured by a blood test. It's described in this study that cirrhosis patients are detected with significantly higher levels of sTREM2 than NASH and simple steatosis patients, while an elevated sTREM2 shows in NASH patients compared to people with steatosis only. That's to say, systemic sTREM2 is associated with the severity of NAFLD, making them superior NASH biomarkers to distinguish different stages in the liver disease progression.

 

In summary, this study not only discussed the origin and function of TREM2+ macrophages in NASH, but also define sTREM2 in plasma as a circulating biomarker that tracks liver disease progression. The expression of bone marrow-derived TREM2 is the key to generating anti-fibrotic macrophages, which can inhibit the proinflammatory transcriptional program of myeloid cells in the liver to limit NASH development, making TREM2 an assumed therapeutic target to promote tissue reverse remodeling in NASH progression.

Labels:

Comments

Post a Comment

Popular posts from this blog

How Haptens Differ from Antigens and Become Immunogens?

The  difference between antigens vs. haptens  is one the most concerning issues for people who are not familiar with them. As a matter of fact, antigens and haptens are similar in many ways. They are both molecules triggering immune responses and acting as antigenic agents. And they both work as immunogens and bind to antibodies although haptens in a different manner.   What distinguishes an antigen mostly from a hapten is that antigens are complete molecules spontaneously triggering immune response whereas haptens are fragmentary small molecules that are unable to elicit immune responses unless they are conjugated to a larger molecule, known as a carrier.   What are Antigens? Antigen s, including proteins, peptides, and polysaccharides, are immunogen   molecules  that can trigger immune response s or naturally bind to   immune   components . An antigen may have one or more epitopes, which are the determinants of recognition and binding to antibod...
Post a Comment
Read more

Review: Creative Biolabs' Model-org Antibodies Fluorescently Labeling Services

Model organisms (Model-org) are non-human species, from which researchers can get insights into other organisms in biological research processes. Various model organism species such as zebrafish, flies, yeast, and rice, greatly contribute to the basic and clinical research in animal husbandry, fishery ， agriculture, forestry, etc.   Investigations on model organisms can be aided by antibody labeling when samples of interest need to be detected, isolated, or purified, though the selection of a proper label can be a challenge.   To select the best antibody labeling way for our Model-org project, we then found Creative Biolabs, one of the most well-established CROs for antibody development. After a comprehensive discussion and consultancy with the scientists at Creative Biolabs, fluorescent tags were  suggested based on our research direction. Fluorescent labels are directly conjugated to the antibody of interest, indicating that we can directly detect the number of fluoresc...
Post a Comment
Read more

Metagenomics Enhances Infectious Disease Surveillance

  Infectious lower respiratory diseases and diarrheal diseases are the leading causes of death globally . And the ongoing COVID-19 pandemic, which has contributed to 4.1 million deaths in 2019, once again is reminding the necessity of proactively identifying early signs of infectious disease outbreaks before things are getting worse. Conventional microbial diagnostics techniques would identify pathogens under specific culture conditions by serological detection of pathogen-associated antibodies or microbial genetic investigation using PCR, but these methods have been seen obvious shortcomings in pathogen coverage. It's highly required to find advanced scientific tools that are more sensitive even with a low microbial load or when targeted microorganisms are not suitable for  in vitro  culture, for which metagenomic approaches that can profile all DNA or RNA of a patient sample are increasingly catching the eyes of researchers.   How metagenomics can be used in infect...
Post a Comment
Read more